Boris Peaker

Analyst Boris Peaker works at COWEN and is focused on the Healthcare sector with 80 price targets and ratings documented since 2011 spanning on 10 stocks. Previously, Boris Peaker worked at OPPENHEIMER. Analyst's average stock valuation to be materialised ratio is 72.27% with an average time for price targets to be met of 165.67 days.

Most recent stock forecast was given on EBS, Emergent BioSolutions Inc at 12-Sep-2022.

Boris Peaker best performing recommendations are on SGEN (SEATTLE GENETICS, INC).
The best stock recommendation documented was for SGEN (SEATTLE GENETICS, INC) at 6/19/2017. The price target of $54 was fulfilled within 8 days with a profit of $7.88 (12.73%) receiving and performance score of 15.92.

Average potential price target upside

• of $49.78 (38.02%) on CLDX (CELLDEX THERAPEUTICS, INC).
• of $11.13 (12.88%) on SGEN (SEATTLE GENETICS, INC).
• of $4.45 (8.73%) on EBS (EMERGENT BIOSOLUTIONS INC).